Mucosal and invasive fungal infections in HIV/AIDS

C A Hage1, M Goldman, L J Wheat

  • 1Indiana University School of Medicine, Indianapolis Department of Veterans Affairs Hospital, USA. lwheat@iupui.edu

Insights

Management of fungal infections in acquired immunodeficiency syndrome (AIDS) has improved due to potent antiretroviral therapy (ART). While ART reduces incidence, immune reconstitution inflammatory syndromes and new antifungal agents require updated treatment strategies for HIV patients.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Pharmacology

Background:

  • Fungal infections were historically common in patients with acquired immunodeficiency syndrome (AIDS).
  • The advent of potent antiretroviral therapy (ART) has significantly reduced the incidence of these infections.
  • Current cases often involve patients with advanced HIV disease, treatment failure, or those treatment-naïve.

Purpose of the Study:

  • To provide an updated review on the management of fungal infections in patients with AIDS.
  • To discuss the impact of ART on the incidence and presentation of fungal infections.
  • To highlight new therapeutic options and challenges in managing these infections.

Main Methods:

  • This review synthesizes current literature on fungal infections in AIDS.
  • It examines the influence of antiretroviral therapy on disease incidence and immune reconstitution.
  • The review considers the emergence of immune reconstitution inflammatory syndromes (IRIS) and new antifungal agents.

Main Results:

  • Antiretroviral therapy has led to a decreased incidence of fungal infections in AIDS patients.
  • Immune reconstitution can reduce infection rates and allow for discontinuation of maintenance therapy.
  • Paradoxical worsening of fungal infections, known as IRIS, can occur due to immune reconstitution.
  • New antifungal agents offer expanded treatment choices.

Conclusions:

  • The management of fungal infections in AIDS has evolved significantly with ART.
  • Updated strategies are necessary to address the changing epidemiology and challenges like IRIS.
  • Continued research and clinical vigilance are crucial for optimal patient outcomes.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...